Introduction
============

Antimicrobial peptides (AMPs) are natural compounds with antimicrobial activity toward a wide range of fungi and bacteria. They are a diverse group of peptides with no consensus sequence associated to their biological activity but sharing common features: most of them are cationic, relatively hydrophobic and amphipathic molecules ([@B60]). Being amphipathic facilitates their selective interaction with negatively charged microbial membranes, so are capable of functioning as membrane-disruption peptides or cell-penetrating peptides interfering with key intracellular processes ([@B60]; [@B40]). In general, AMPs seem to act on low-affinity targets, so with little propensity to develop resistance in microbial targets ([@B60]; [@B20]; [@B46]; [@B49]; [@B59]; [@B17]). The growing problem of resistance to conventional antibiotics together with the lack of new effective molecules has stimulated interest in developing AMPs as an alternative ([@B20]; [@B61]; [@B17]). In addition, AMPs have different mechanisms of action to other antimicrobials, reinforcing their enormous potential as a complement to conventional antibiotics. They have multiple applications in medical therapies, food preservation and crop protection ([@B34]; [@B32]; [@B35]; [@B26]).

Although research on AMP development has been highly active recently, few molecules have entered the market. Major challenges to be solved before natural AMPs can be fully exploited relate to their target specificity and stability, as well as production costs. The advances in peptide synthesis have enabled the *de novo* synthesis and rational design of AMPs with improved properties ([@B34]), with the hexapeptide PAF26 (RKKWFW) identified through a combinatorial approach as a novel peptide with specific antifungal activity and cell penetrating properties ([@B31]), and PAF102 rationally designed as a modified concatemer of PAF26 of 29 amino acid residues with high potency and specificity toward fungal cells, low toxicity to mammalian cells, high stability to proteolysis and for optimal production in plants ([@B30]). Other strategies are based on the modification of natural AMPs, such as the cecropin::melittin hybrids that are designed to decrease the toxicity of the high hemolytic melittin peptide ([@B14]; [@B5], [@B6]). However, some naturally occurring peptides, such as the 37 residues peptide cecropin A (CecA) isolated from insects, have potent lytic activity against major bacterial and fungal pathogens without additional modifications ([@B50]; [@B14]; [@B38]). More importantly, CecA has no lytic activity against mammalian erythrocytes or lymphocytes ([@B50]; [@B51]). These properties make this natural peptide a good candidate to be developed as an antimicrobial in multiple fields of applications.

The other major limitation for most AMPs is their production costs. The amount of AMPs produced in living organisms is very low, and their extraction and purification requires complex and costly procedures. Chemical synthesis is only economically viable for short peptides and high value applications. Their peptidic nature enables production through biotechnological systems, but, depending on the nature of the AMPs, their production in conventional microbial systems is frequently not very efficient due to toxicity toward host cells or proteolysis of the products ([@B54]; [@B11]; [@B24]; [@B58]). Recently, our group has demonstrated that rice seeds are good biofactories for linear AMPs that, otherwise, are difficult to produce in biological systems ([@B12], [@B13]; [@B37], [@B36]). We found that, interestingly, PAF102 and CecA could be efficiently produced in rice seeds as oleosin fusion proteins targeted to oil bodies (OBs) ([@B37]; [@B13]). OBs, also known as lipid droplets (LDs), are specialized structures composed mainly of a core of neutral lipids (triacylglycerols and steryl esters) surrounded by a monolayer of phospholipids containing a number of proteins that differ considerably between species ([@B15]). Oleosins are plant specific proteins with a structural role in OB formation and stabilization ([@B53]). They have been used as a carrier of recombinant proteins to OBs, facilitating their subsequent purification from plant material ([@B55]). Consequently, plant OBs have emerged as a target for biotechnological production of recombinant proteins ([@B44]; [@B41], [@B42]; [@B9]).

The purpose of the present study was to investigate whether oleosin fusion technology could be transferred to the well-established production system based on *Pichia pastoris* to efficiently produce AMPs. *P. pastoris* has been developed as an excellent host for the production of biopharmaceuticals and industrial enzymes. The growth of yeast is fast, with very high cell densities producing grams of recombinant protein per liter of culture ([@B3]). Here, PAF102 was efficiently produced in *P. pastoris* when fused to the rice plant Oleosin 18, whereas no accumulation of CecA was detected. The plant oleosin was correctly targeted to the LDs in the heterologous system and carries the PAF102 peptide, leading to high accumulation of the fusion protein in these vesicles. Moreover, the recombinant LDs were easily isolated by flotation on density gradients for PAF102 purification. We also show that the recovered PAF102 was biologically active against pathogenic fungi. Our results demonstrate that *P. pastoris* allows fast and efficient production of AMPs through oleosin fusion technology.

Materials and Methods {#s1}
=====================

Plasmid Constructs, Yeast Strains and Growth Conditions
-------------------------------------------------------

A construct was prepared to produce the fusion protein of Oleosin 18 to the Green Fluorescent Protein (Ole18-GFP) in *P. pastoris* ([Figure 1](#F1){ref-type="fig"}). The open reading frame of the rice *Ole18* (LOC_Os03g49190) without the stop codon was amplified by PCR from the plant vector pC::pOle18:Ole18-CecA ([@B37]) using the primers indicated in [Supplementary Table 1](#SM1){ref-type="supplementary-material"} (EcoRI_Ole18fwd and Ole18rev) and the Phusion high-fidelity DNA polymerase (Thermo Scientific, Spain). The *GFP* open reading frame was amplified from the pYGWY yeast vector containing the GFP tag ([@B47]) using the GFPfwd and XbaI_GFPrev primers ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). Amplified DNA fragments were assembled by the Gibson reaction using the NEbuilder HiFi DNA assembly master mix (New England Biolabs, United States). The assembled *Ole18-GFP* fragment was then digested with the *EcoR*I and *Xba*I restriction enzymes, and cloned into these restriction sites of the integrative yeast vector pGAPHA for expression, driven by the Glyceraldehyde-3-Phosphate Dehydrogenase (*GAP*) constitutive promoter. This plasmid derives from pGAPZA (Invitrogen, Thermo Scientific, Spain), in which the Zeocin^TM^ resistance marker was replaced by the hygromycin resistance one ([@B2]).

![Ole18-GFP is targeted to *P. pastoris* LDs **(A)** Gene construct used to produce the Ole18-GFP fusion protein in *P. pastoris* cells. Expression of the fusion gene encoding the rice Ole18 protein tagged with the Green Fluorescent Protein (Ole18-GFP) was under the control of the constitutive promoter *GAP1* (promGAP1) and the *AOX1* terminator (tAOX1). Arrows indicate the position of primers used for preparing the construct **(B)** Confocal laser microscopy images of cells accumulating the Ole18-GFP protein visualized under fluorescence for GFP, Nile red, and the merged GFP and Nile red image. The corresponding bright field image (BF) is also shown. Scale bar = 2 μm.](fmicb-10-01472-g001){#F1}

Two more constructs were prepared to produce the Ole18-CecA and Ole18-PAF102 fusion proteins in *P. pastoris* ([Figure 2](#F2){ref-type="fig"}). The *Ole18-CecA* open reading frame was amplified by PCR from the plant vector pC::pOle18:Ole18-CecA ([@B37]) using the EcoRI_Ole18fwd and XhoI_CecArev primers, shown in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}. The *Ole18-PAF102* was amplified from the pC::pOle18:Ole18-PAF102 ([@B13]) using the same forward primer and the XhoI_PAF102rev as the reverse primer ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). The fusion genes were introduced into the pGAPHA plasmid as *EcoR*I-*Xho*I fragments behind the *GAP* promoter. As a control, we also prepared a construct for the single Ole18 protein ([Figure 2](#F2){ref-type="fig"}). For that, the *Ole18* open reading frame was amplified with EcoRI_Ole18fwd and XhoI_Ole18rev primers ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}), and transferred to the pGAPHA plasmid as an *EcoR*I-*Xho*I fragment.

![Ole18-PAF102 accumulates in *P. pastoris* LDs. **(A)** Gene constructs used to produce the rice Ole18 and the Ole18-CecA and Ole18-PAF102 fusion proteins in *P. pastoris cells*. Ole18 protein and the CecA and PAF102 antimicrobial peptides are linked through the TEV protease recognition site (PRS). Arrows indicate the position of primers used for preparing the constructs. **(B)** Amino acid sequence of the Ole18-CecA and Ole-PAF102 fusion proteins with Ole18 protein (red) linked through PRS (gray) to CecA or PAF102 peptides (black). Arrows indicate TEV protease cleavage site. **(C)** Immunoblot analysis of equivalent total protein extracts (lysates) and LDs from *P. pastoris* cell cultures transformed with empty vector (EV) or the indicated gene constructs, using anti-PAF102, anti-Ole18 or anti-Erg6 antibodies as indicated. Ponceau staining of the membrane is shown as protein loading control (25 μg of total protein). Red arrows indicate Ole18 protein bands and black the Ole18-PAF102 fusion protein bands. Molecular weight markers are indicated in kDa on the left.](fmicb-10-01472-g002){#F2}

An additional construct was prepared for the production of Diacylglycerol O-AcylTransferase 1 (Dgat1) from *Arabidopsis thaliana* (At2g19450) in *P. pastoris*. In this case the open reading frame was amplified from the G16373 clone provided by the Arabidopsis Biological Resource Center (ABRC, Ohio State University, United States) using the primers Dgat1_fwd and Dgat1_rev ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}). The amplified fragment was inserted into the pGAPZA plasmid (Invitrogen, Thermo Scientific, Spain) using the Gibson assembly reaction. This plasmid allows gene expression under the control of the *GAP* promoter and confers Zeocin^TM^ resistance. All the constructs were verified by DNA sequencing.

Gene constructs were transferred to the wild-type *P. pastoris* strain X-33 by electroporation. Recombinant colonies were isolated using the appropriate antibiotic selection at 100 μg/ml of Zeocin^TM^ or 300 μg/ml of hygromycyn B, and then confirmed by PCR. Two to three independent colonies were analyzed by transformation event with similar results in the different assays. Yeast cells were grown in YPD medium (1% yeast extract, 2% peptone, and 2% glucose) at 30°C. Cell growth was monitored by measuring the optical density at 600 nm (OD~600~) of the culture at different time points, or by plating serial 1/10 dilutions of an exponential growing culture on YPD agar plates.

Lipid Droplets Fractionation
----------------------------

Lipid droplets (LDs), along with their bound proteins, were isolated by density gradient centrifugation provided by Ficoll (Sigma-Aldrich, Spain), as previously described, with some modifications ([@B33]). Basically, the method was adapted to lyse the cells by sonication on ice. Cells grown in YPD medium to late logarithmic phase were resuspended in Ficoll buffer I (12% Ficoll, 10 mM Tris--Hcl, 200 μM EDTA) at a concentration of 2 ml/g of cells. Cells were then lysed through seven consecutive cycles of sonication of 20 s each. After clarifying the lysate from the cell debris by low speed centrifugation, the supernatant was overlaid with the same volume of Ficoll buffer I and centrifuged at high speed (100,000 *g*) for 1 h in a SW40 rotor. LDs were recovered in the floating white layer, and then, were overlaid with a volume of Ficoll buffer II (8% Ficoll, 10 mM Tris--HCl, 200 μM EDTA). After a second round of flotation-centrifugation under the same conditions, LDs were obtained at high purity in the floating fat pad. The purity and integrity of recovered LDs were confirmed by selective staining with Nile red (1 ng/ml, Sigma-Aldrich, Spain) and fluorescence microscopy visualization.

Immunoblot Analysis of LD-Associated Proteins and PAF102 Purification
---------------------------------------------------------------------

LD-associated proteins were solubilized in loading buffer, separated by SDS-PAGE (15% acrylamide, [@B28]), transferred to nitrocellulose membranes and immunodetected with different antibodies: anti-Ole18 (1:2000 dilution, [@B37]), anti-CecA (1:500 dilution, [@B16]), anti-PAF102 (1:1000 dilution, [@B13]), and anti-Erg6 (1:500 dilution, [@B43]). PAF102 accumulation was estimated on immunoblot by quantification of signal intensities of Ole18-PAF102 to known amounts of synthetic PAF102, using the Quantity Tools Image Lab^TM^ Software (Version 5.2.1) included in the ChemiDoc^TM^ Touch Imaging System (Bio-Rad, United States).

OBs containing Ole18-CecA or Ole18-PAF102 proteins were isolated from *pOle18:Ole18-CecA* and *pOle18:Ole18-PAF102* rice seeds as previously described ([@B37]; [@B13]). OB fractions obtained from ten seeds and resuspended in 100 μl buffer (0.2 M sucrose, 10 mM phosphate buffer pH 7.6) were separated into four aliquots (25 μl each). Protease inhibitor cocktail (Sigma-Aldrich, Spain) was added to two of these, and then 25 μg of total protein extracts from the empty vector *P. pastoris* strain was added to all them. One with and one without the inhibitor were immediately frozen and the other two incubated at room temperature overnight. Proteins were then analyzed by immunoblot using anti-Ole18 specific antibodies.

PAF102 was recovered from the LDs containing the Ole18-PAF102 fusion protein by digestion with Tobacco Etch Virus (TEV) protease (Invitrogen, Thermo Fisher Scientific, Spain, 1:100), as the Ole18 protein was linked to the PAF102 peptide through a TEV protease recognition site (ENLYFQ/G). Proteolytic digestion was overnight at 30°C in TEV protease buffer. The estimated efficiency of the TEV protease was based on the disappearance of the Ole18-PAF102 signal by immunoblot analysis. The released PAF102 was immunodetected using anti-PAF102 antibodies by western-blot, after acetone precipitation, separation in Tricine-SDS-PAGE (18% acrylamide, [@B48]) and transfer to nitrocellulose membranes (Whatman^®^ Potran 0.2 μm).

Confocal and Fluorescence Microscopy
------------------------------------

Cells of *P. pastoris* carrying the different gene constructs were visualized under confocal fluorescent microscopy with a Leica TCS SP5 microscope. For that, cells grown overnight in liquid medium to late logarithmic phase (1 ml of cultures) were concentrated by centrifugation for 2 min at 600 *g*, washed in water, resuspended in phosphate-buffered saline (PBS) containing 1 ng/ml of Nile red and directly visualized under a coverslip. GFP signal was detected at 500--550 nm through excitation with an Argon ion laser emitting a 488 nm and Nile red signal at 570--670 nm using DPSS laser emitting at 561 nm.

Cell viability was evaluated by fluorescein diacetate (FDA, Sigma-Aldrich, Spain) staining ([@B25]). Cell cultures grown at logarithmic phase (OD~600~ = 1) were concentrated, washed and resuspended in PBS containing FDA (10 μg/ml) and stained for 20 min. After washing, the cells were visualized under fluorescent microscopy using an Axiophot Zeiss upright wide field fluorescence microscope.

The size of the intracellular LDs was estimated by image analysis using ImageJ software. The Z-projection fluorescent images were converted to binary images by applying a threshold that highlights all the structures to be measured. The area of LDs was determined using the particle analysis tool and taking into account only those droplets with spherical geometry. The 100 LDs measured per line were clustered in different size ranges and the percentage of LDs in each group was calculated. To determine the amount of LDs in the different cell lines, LDs were counted in three different replicas of the projection images of 30 cells from at least three different experiments.

Antifungal Activity Assays
--------------------------

Growth inhibition assays of *Fusarium proliferatum* were in 96-well flat-bottom microtiter plates as previously described, with minor changes ([@B30]). Basically, 50 μl of fungal conidia (5 × 10^4^ conidia/ml), in 1/10 diluted potato dextrose broth (PDB) containing 0.02% (w/v) chloramphenicol, were mixed in each well with 50 μl of LD fractions. The Ficoll buffer II of LD fractions was exchanged with sterile deionized H~2~O containing 0.02% Tween-20 using Zeba^TM^ Spin Desalting columns (Thermo Fisher Scientific, Spain). Samples were prepared in triplicate. Plates were incubated with agitation for 72 h at 28°C. Fungal growth was monitored every 24 h by measuring the OD~600~ using a Spectramax M3 reader (Molecular Devices, United States), and mean values and standard deviation (SD) were calculated. Experiments were repeated twice with similar results.

Results
=======

Ole18-GFP Fusion Protein Is Targeted to *P. pastoris* LDs
---------------------------------------------------------

A gene construct was prepared to study the subcellular localization of the rice Ole18 protein in *P. pastoris* ([Figure 1A](#F1){ref-type="fig"}). This construct was designed to express a *Ole18-GFP* fusion gene under the control of the constitutive promoter *GAP1* in the integrative yeast vector pGAPHA. Cell colonies carrying the gene construct were obtained by genetic transformation. Their growth rate in rich medium was similar to cells transformed with the empty vector (EV). Confocal fluorescence microscopy revealed the GFP signal surrounding spherical intracellular vesicles with diameters of 0.1--1 μm ([Figure 1B](#F1){ref-type="fig"}). These vesicles co-localized with those labeled with Nile red, a fluorescent stain for neutral lipids used as an LD marker ([@B18]). These results indicate that the Ole18-GFP fusion protein is produced and accumulates mostly in the periphery of LDs of *P. pastoris* cells. Hence, the rice Ole18 protein was efficiently produced and correctly targeted to LDs in this heterologous system, as previously reported for other plant oleosin proteins produced in *Saccharomyces cerevisiae* yeast cells ([@B52]; [@B7]; [@B45]; [@B22]; [@B56]). Our results also suggest that Ole18 can be used as a carrier protein to LDs in Pichia cells.

Ole18-PAF102 Accumulates in *P. pastoris* LDs
---------------------------------------------

To investigate whether the oleosin fusion technology can be used to produce AMPs in *P. pastoris*, we prepared two new gene constructs ([Figure 2A](#F2){ref-type="fig"}). They were designed to produce the CecA and PAF102 antimicrobial peptides as fusion to the rice Ole18 protein ([Figure 2B](#F2){ref-type="fig"}). Proteins were linked through a TEV protease recognition site for the subsequent release of the AMPs from the fusion protein. We also prepared an additional construct to produce the single Ole18 protein as a control ([Figure 2A](#F2){ref-type="fig"}). Transformed colonies were obtained for each construct, and integration of the transgenes was confirmed by PCR. Total protein extracts from the recombinant cultures grown in YPD media to the late logarithmic phase were analyzed by SDS-PAGE and immunoblotting ([Figure 2C](#F2){ref-type="fig"}, right panels). Using specific antibodies to the rice Ole18, we detected a band of the expected size (around 18 kDa) in the lysates obtained from *Ole18* strain cultures ([Figure 2C](#F2){ref-type="fig"}, red arrows). A higher band was detected in the lysates from *Ole18-PAF102* cultures ([Figure 2C](#F2){ref-type="fig"}, black arrows) with an apparent size around 23 kDa, the expected size for the Ole18-PAF102 fusion protein (the theoretical molecular weight is 22.17 kDa). This band was also immunodetected using the anti-PAF102 specific antibodies. Our results indicate that the Ole18-PAF102 fusion protein was produced and stably accumulated in *P. pastoris* cells.

In contrast, no immunoreactive band was detected in the protein extracts from the *Ole18-CecA* cultures, using anti-Ole18 ([Figure 2C](#F2){ref-type="fig"}) or anti-CecA antibodies (data not shown). The theoretical molecular weight of Ole18-CecA fusion proteins is 22.32 kDa. Up to five independent *Ole18-CecA* transformed colonies confirmed for transgene integration were tested, with similar results. This data suggests that the Ole18-CecA fusion protein did not accumulate at detectable levels in the yeast cells.

We then isolated the LDs from the different recombinant yeast strains by gradient density centrifugation. LD fractions were stained with Nile red and visualized under fluorescence and bright field microscopy. Samples had a high content of intact, high purity LDs. After solubilizing in SDS loading buffer, the LD proteins were separated by SDS-PAGE and immunodetected using specific anti-Ole18 antibodies ([Figure 2C](#F2){ref-type="fig"}, right upper panel). We clearly detected the presence of Ole18 (red arrow) and Ole18-PAF102 (black arrow) proteins in the LD fractions, but not the Ole18-CecA protein ([Figure 2C](#F2){ref-type="fig"}, right upper panel). The isolated fractions were additionally confirmed as LD fractions by immunodetection of the Erg6 protein ([Figure 2C](#F2){ref-type="fig"}, right lower panel), an enzyme of the ergosterol biosynthetic pathway known to be associated with the LDs in *P. pastoris* cells ([@B21]). These results show that Ole18-PAF102 accumulates in *P. pastoris* LDs.

Ole18-CecA Is Susceptible to *P. pastoris* Proteases
----------------------------------------------------

Given that Ole18-CecA was not detected in total or LD protein extracts from the recombinant yeast strain, we hypothesized a potential toxicity problem related to the CecA antimicrobial activity, and this would lead to growth defects. However, when the growth of *Ole18-CecA* cells was monitored, we found they grew similarly to the strains transformed with the EV, the *Ole18*, and the *Ole18-PAF102* gene constructs ([Figure 3A](#F3){ref-type="fig"}). Additionally, the morphological appearance and viability of *Ole18-CecA* cells was similar to EV transformed cells when visualized under fluorescence microscopy after fluorescein diacetate viable cell staining ([Figure 3B](#F3){ref-type="fig"}). We found no evidence of toxicity associated to the *Ole18-CecA* gene in our experiments.

![Ole18-CecA is susceptible to *P. pastoris* proteases. **(A)** Growth of recombinant strains carrying empty vector (EV), *Olel8, Olel8-PAF102, Olel8-CecA.* Aliquots of 5 μl of ten serial dilutions of log phase cultures (OD~600~ = 1) were spotted on YPD agar media and allowed to grow for 2 days at 30°C. **(B)** Images of fluorescence and bright field microscopy of EV and *Olel8-CecA* cells after fluorescein diacetate (FDA) viability staining. **(C)** Immunoblot of OB fractions isolated from rice seeds producing Ole18-CecA^∗^ or Ole18-PAF102^∗^ fusion proteins, in the presence of total protein extracts (25 μg) from EV yeast cells, supplemented without (--) or with (+) protease inhibitors, incubated (I) or not (N) overnight at room temperature.](fmicb-10-01472-g003){#F3}

Another possible scenario could be that Ole18-CecA does not accumulate due to instability in the yeast cells. To test the stability, we obtained the fusion protein from *promOle18:Ole18-CecA* rice seeds previously generated in our group ([@B37]). These rice seeds accumulate large amounts of Ole18-CecA protein in OBs (40 μg per gram of rice seeds). Isolated rice OBs containing Ole18-CecA protein were incubated *in vitro* with *P. pastoris* protein extracts from EV strain, and then analyzed by immunoblotting ([Figure 3C](#F3){ref-type="fig"}). There was a clear reduction in the amount of Ole18-CecA after incubation with Pichia protein extracts unless protease inhibitors were added. As a control, we also analyzed the Ole18-PAF102 fusion protein produced in rice seeds ([@B13]). Interestingly, Ole18-PAF102 remained stable after overnight incubation with the Pichia protein extracts. These results suggest that Ole18-CecA does not stably accumulate in *P. pastoris* cells because it is susceptible to the yeast proteases, whereas Ole18-PAF102 is more resistant to yeast proteases ([Figure 3C](#F3){ref-type="fig"}) and accumulates to high levels in the yeast system ([Figure 2C](#F2){ref-type="fig"}). In contrast, accumulation of Ole18-CecA is higher than Ole18-PAF102 in rice ([Figure 3C](#F3){ref-type="fig"}), probably associated to a higher susceptibility of Ole18-PAF102 to rice proteases. Therefore, *P. pastoris* seems to be an efficient system for the production of Ole18-PAF102, and hereinafter we focus on this antifungal peptide.

Ole18-PAF102 Production Induces Proliferation of LDs in *P. pastoris*
---------------------------------------------------------------------

To further characterize the production of Ole18-PAF102 in the yeast cells, we closely inspected the recombinant cells under confocal microscopy ([Figure 4A](#F4){ref-type="fig"}). We observed that their morphological appearance was similar to *EV* and *Ole18* cells, but they contained a higher number of LDs, with the cell-to-cell LD number and size highly variable. As the number of LDs was difficult to quantify at the cell level, we used a large population (30 cells), detecting a statistically significant increase in the cells accumulating Ole18-PAF102 ([Figure 4B](#F4){ref-type="fig"}). Although there was also a tendency for a higher number of LDs in *Ole18* cells, no significant differences were quantified in comparison to EV cells. These results differ from reports in the literature showing an induction of LD proliferation mediated by other plant oleosins in the yeast *S. cerevisae* ([@B52]; [@B22]; [@B23]; [@B56]). We also observed an increase in the size of the recombinant LDs, more pronounced in those of Ole18-PAF102 ([Figure 4C](#F4){ref-type="fig"}). Our results suggest that the antifungal PAF102 peptide fused to Ole18 determines an increase in LDs in *P. pastoris* cells.

![Ole18-PAF102 production induces proliferation of LDs in *P. pastoris* cells **(A)** Confocal microscopy images of EV, Ole18, and Ole18-PAF102 recombinant cells at late log growth phase stained with Nile red. Bright field (BF) images, and fluorescence and BF merged images are also shown. Images correspond to single focal sections. Bars = 2 μm. **(B)** Total number of LDs per 30 cells of the indicated strains. LDs were counted in two replicates per assays and five independent assays (*n* = 10). Asterisk denotes statistically significant differences (Tukey test, *p* \< 0.005) **(C)** Distribution of range sizes (area in μm^2^) from 50 LDs from cells of indicated strains.](fmicb-10-01472-g004){#F4}

*A. thaliana* *Dgat1* Expression Induces LD Formation in *Ole18-PAF102* Yeast Cells
-----------------------------------------------------------------------------------

With the purpose to increase the amount of LDs and presumably the accumulation of Ole18-PAF102 in the yeast cells, we expressed the *Dgat1* gene from *A. thaliana* in *P. pastoris* cells. Dgat enzymes catalyze the acyl-CoA-dependent acylation of sn-1,2-diacylglycerol to produce triacylglycerol (TAG) ([@B29]). This is the rate-limiting activity for TAG biosynthesis and a target for engineering increase in oil content in microorganisms ([@B29]). The expression of the Arabidopsis *Dgat1* in *S. cerevisiae* has been reported to enhance the content in TAG and LD formation ([@B10]; [@B4]). We prepared a new construct containing the coding sequence of the *AtDgat1* in the integrative pGAPZA vector, which carries another selection marker to allow double transformant selection ([Figure 5A](#F5){ref-type="fig"}). To easily monitor the LD content, *Dgat1* transformation was first examined in the *Ole18-GFP* strain. Visualization of cells under confocal microscopy revealed an increase in the content of LDs in the recovered transformant cells ([Figure 5B](#F5){ref-type="fig"}). Although there was a large variability among cells, most of *Ole18-GFP* possessed one or two LDs whereas the double transformant *Ole18-GFP*/*Dgat1* had three or four LDs per cell. The number of LDs was significantly higher in those cells expressing the *Dgat1* gene ([Figure 5C](#F5){ref-type="fig"}), indicating that expression of the Arabidopsis *Dgat1* gene induces LD formation in *P. pastoris*, as reported for *S. cerevisiae* ([@B10]; [@B4]).

![*A. thaliana* Dgat1 expression induces LD formation in Ole18-PAF102 yeast cells **(A)** Gene construct introduced into the pGAPZA vector for producing *A. thaliana* Diacylglycerol o-acyltransferase (Dgat1) enzyme (At2g19450) in *P. pastoris*. **(B)** Confocal microscopy images of Ole18-GFP cells with or without the Dgat1 construct, as indicated. Bright field (BF) and fluorescence merged images are shown. **(C)** Total number of LDs per 30 cells of the indicated strains. LDs were counted in three replicates. Asterisk denotes statistically significant differences (Tukey test, *p* \< 0.005) **(D)** Confocal microscopy images of Nile red stained Ole18-PAF102 cells with or without the Dgat1 construct as indicated. Bright field (BF), and fluorescence and BF merged images are also shown. Images correspond to single focal sections. **(E)** Total number of LDs per 30 cells of the indicated strains. LDs were counted in three replicates. Asterisk denotes statistically significant differences (Tukey test, *p* \< 0.005) **(F)** Distribution of range sizes (area in μm^2^) from 50 LDs from strain cells indicated. **(G)** Growth of indicated strain cultures. Graph represents the mean OD~600~ ± SD value of triplicate cultures measured every 2 h. Bars = 2 μm.](fmicb-10-01472-g005){#F5}

We then introduced the *Dgat1* gene construct in the *Ole18-PAF102* strain. Double transformants were recovered and visualized under confocal microscopy. Nile red staining of LDs revealed accumulation of cellular LDs mediated by the expression of the *Dgat1* gene ([Figure 5D](#F5){ref-type="fig"}). We found a statistically significant increase of around three times in the number of LDs of double transformant cells ([Figure 5E](#F5){ref-type="fig"}), which not only had more LDs, but were also larger in size ([Figure 5F](#F5){ref-type="fig"}). Consistent with our previous observations, there was high variability in the number and size of LDs in the cell population. Monitoring cell growth through optical density (OD~600~), we also found that cells expressing *Dgat1* were slower reaching high densities ([Figure 5G](#F5){ref-type="fig"}). This slow growth was not only measured in the *Ole18-PAF102* strain but also in *EV* cells, and both EV and *Ole18-PAF102* single transformants had similar growth rates. This indicates that the delay may be determined by *Dgat1* gene expression. Altogether, our results show that the LD content is further enhanced in *Ole18-PAF102* strain by expression of the Arabidopsis *Dgat1* gene, albeit requiring a longer period of culture growth.

Biologically Active PAF102 Is Recovered From Yeast Cells
--------------------------------------------------------

Knowing that double transformant *Ole18-PAF102/Dgat1* cells contain a high number of LDs, and that Ole18-PAF102 is accumulated in these LDs, we evaluated the amount of PAF102 peptide produced by this strain. We isolated the LDs by density gradient centrifugation and analyzed their Ole18-PAF102 content by immunodetection. As shown in [Figure 6A](#F6){ref-type="fig"}, Ole18-PAF102 accumulation was higher in the *Dgat1* expressing strain and correctly targeted to LDs. We estimated that the fusion protein accumulates at 67 ± 2 mg/l in the *Ole18-PAF102* strain, and reaches up to 180 ± 5 mg/l in the *Ole18-PAF102/Dgat1* strain. This represents a near three-fold increase in the fusion protein accumulation levels, congruently with the three-fold increase in cellular LD content ([Figure 5E](#F5){ref-type="fig"}).

![Biologically active PAF102 is recovered from yeast cells. **(A)** Immunoblot of total protein extracts (25 μg) and LD proteins from *P. pastoris* cell cultures transformed with empty vector (EV) or the indicated gene constructs, using anti-Ole18 or anti-PAF102 antibodies as indicated. **(B)** Immunoblot analysis of LDs fractions before (--) or after (+) TEV protease digestion using anti-PAF102 or anti-Ole18 antibodies as indicated. LDs were from Ole18 and Ole18PAF102/Dgat1 (\#1 and \#2 independent colonies) strains. **(C)** Immunoblot analysis of PAF102 peptide released from the fusion Ole18-PAF102 protein. Proteins from LDs were precipitated with acetone after TEV protease digestion and separated in Tricine-SDS-PAGE. Synthetic PAF102 (sPAF102, 25 or 50 ng), alone or in combination with the EV proteins, was run in parallel for comparative purposes **(D,E)** *F. proliferatum* growth inhibitory assays by indicated LD fractions in comparison to synthetic PAF102 (sPAF102) at varying concentrations **(D)** or by TEV digested LDs fractions in comparison to EV LDs supplemented with sPAF102 **(E)**.](fmicb-10-01472-g006){#F6}

Using this high producer *Ole18-PAF102/Dgat1* strain, we assessed the recovery of the single PAF102 peptide from the LDs containing the Ole18-PAF102 fusion protein. TEV protease was used to digest the recombinant LD fraction since the Ole18 and PAF102 polypeptides were linked through the TEV protease recognition site (PRS). In immunoblot analysis of LD fractions after proteolytic digestion ([Figure 6B](#F6){ref-type="fig"}), we observed that the fusion protein detected by anti-PAF102 antibodies was almost absent (upper panel), and a protein slightly larger than Ole18 appeared, recognized by anti-Ole18 antibodies (lower panel). After TEV protease digestion, most of the PRS remained attached to the Ole18 protein. This gives the Ole18 released from the fusion protein by TEV protease digestion a theoretical molecular weight of 18.25 kDa, whereas the single Ole18 is only 17.15 kDa. The bands detected in western-blot analysis are consistent with this difference in size and suggest that the fusion protein was processed by the TEV protease. Based on the disappearance of the fusion protein in different assays, the TEV protease efficiency was calculated at 86% ± 10.5 on average. This data indicates a high efficiency of proteolytic processing of the fusion protein Ole18-PAF102 on intact LDs. We then investigated the presence of the PAF102 single peptide in the protease digested fractions. We immunodetected a polypeptide in the Ole18PAF102 LDs with similar mobility to the synthetic PAF102 (sPAF102) added to the EV LDs, or to the sPAF102 alone ([Figure 6C](#F6){ref-type="fig"}). This band was not present in Ole18 LDs or in non-digested Ole18PAF102 LDs, indicating that the fusion protein was correctly processed and the PAF102 released.

To characterize the released PAF102 peptide, we tested the antifungal activity of the LDs fractions before and after TEV protease digestion. For that, we monitored the growth of *F. proliferatum* in the presence of LDs at different concentrations. We did not detect any fungal growth inhibitory activity in the intact LD fractions, regardless of whether they were from EV, *Ole18* or *Ole18-PAF102* strains ([Figure 6D](#F6){ref-type="fig"}), whereas the sPAF102 completely inhibited *F. proliferatum* growth at the very low concentration of 2 μM. This data indicates that the fusion protein Ole18-PAF102 was not active, at least when embedded into LDs. However, TEV protease digested Ole18-PAF102 LDs clearly inhibited the growth of *F. proliferatum*, and the inhibitory activity was equivalent to that of EV LDs supplemented with sPAF102 and incubated with TEV protease ([Figure 6E](#F6){ref-type="fig"}). It is worth noting that the synthetic PAF102 was more active in the presence of EV LDs and TEV protease, completely inhibiting fungal growth at the even lower concentration of 0.25 μM. Given that Ole18 LDs and TEV protease did not have any inhibitory activity ([Figure 6E](#F6){ref-type="fig"}), TEV protease could be assisting PAF102 activity. Our results demonstrate that when PAF102 is produced in *P. pastoris* using the oleosin fusion technology, it is biologically active and equivalent to that produced by chemical synthesis.

Discussion
==========

This study reports that *P. pastoris* is an excellent cell factory for the fast and efficient biotechnological production of the antifungal PAF102 peptide, and probably other PAF peptides. The process developed here is an innovative system based on the plant oleosin fusion technology that we successfully transfer to the heterologous yeast system. It has so far been difficult to produce rationally designed PAF antifungal peptides in conventional microbial expression systems, probably due to toxicity toward host cells. We recently demonstrated that these bioactive peptides could be produced in plant biofactories as oleosin fusion proteins ([@B13]). The fusion of PAF102 to the rice Ole18 protein reduces its toxicity to the host cells allowing its accumulation to large amounts. We show here that the Ole18-PAF102 fusion protein is also produced in yeast cells and targeted to LDs where large amounts accumulate. By coexpressing the Arabidopsis *Dgat1* gene, *P. pastoris* cells produced up to 180 mg/l of PAF102 peptide in only 4 days. This yield was obtained from shake-flash cultures, and typically recombinant protein yield can be increased in fermenter cultures. This demonstrates that our new system is a considerable improvement on the previous rice-seed based system in terms of production times and yields of commercial relevance.

Nevertheless, the natural CecA peptide is not produced at detectable levels in this *P. pastoris* system, although it was efficiently produced in rice seeds when fused to Ole18, even to higher levels than PAF102 ([@B37]). Recombinant protein production is not only dependent on gene expression and protein synthesis but also on its stability in host cells to allow its accumulation to significant amounts. Therefore, the lack of Ole18-CecA accumulation to detectable levels by immunoblot analysis might be due to instability in *P. pastoris* cells. Indeed, our results show that CecA is highly susceptible to the yeast proteases. In contrast, PAF102 seems to be more resistant to Pichia proteases and accumulates to high levels. Reports have been already published on the high susceptibility to proteolytic degradation of CecA by fungal proteases ([@B8]) or of CecA-derived peptides by tobacco plant proteases ([@B14]). However, CecA stably accumulated in transgenic rice plants, suggesting limited proteolysis by rice proteases ([@B16]; [@B12]; [@B37]). This data indicates differential degradation of CecA by host proteases, with its stability varying from one system to another: the stability of CecA to protein extracts derived from the host system should first be tested when planning to produce CecA in a new system. Still, the use of protease-deficient strains might improve production of CecA in *P. pastoris*. These strains have been used for the production of protease-sensitive proteins with variable success depending on the proteases involved in the degradation events ([@B3]). Our results suggest that the efficiency of the production system here developed would be dependent on the peptide to be produced.

Oleosin proteins have an important structural role in facilitating the formation and stability of plant LDs. They are small lipophilic proteins with a conserved central hydrophobic domain, inserted within the phospholipid bilayer of LDs, and two variable amphipathic N and C terminal domains covering the LD surface ([@B1]). Oleosins have an intrinsic affinity to membranes containing neutral lipids, associating spontaneously with them and assisting their sequestration into domains and ultimately in the formation of a particle filled with neutral lipids. Yeast LDs do not have similar structural proteins, but perform their functions properly ([@B27]). However, oleosins from different plant species produced in *S. cerevisiae* cells target LDs and induce the formation of LDs ([@B52]; [@B22]; [@B23]; [@B56]). In agreement with these reports, rice Ole18 targets and stably accumulates in LDs in *P. pastoris*. The fusion of PAF102 to the Ole18 in the C-terminal also targets LDs, with the hydrophobic domain of Ole18 embedding into the TAG matrix and the PAF102 remaining on the surface. There were more and larger LDs in the cells accumulating the Ole18-PAF102 fusion protein than in those accumulating only the Ole18. It seems that the presence of PAF102 stabilizes the recombinant LDs and promotes their formation, probably due to the cationic and amphipathic character of PAF102 and its phospholipid affinity. This suggests that the oleosin fusion technology could be successfully applied to other AMPs with a similar cationic and amphipathic character.

A valuable addition to the production system is the coexpression of *AtDagt1* and *Ole18-PAF102* genes. *AtDag1* expression enhances the TAG content in yeast cells ([@B10]; [@B4]). This high content of TAG leads to overaccumulation of the Ole18-PAF102 fusion protein, resulting in high yields of the recombinant protein. This is consistent with the requirement of TAGs for the stable accumulation of the *A. thaliana* Oleosin 1 in yeast cells ([@B22]). Oleosin 1 was easily degraded in mutant strains of *S. cerevisae* deficient in TAGs that were not able to produce and to accumulate neutral lipids. In contrast, cells with a high content of TAGs offer sufficient anchoring surface for the Ole18-PAF102, providing stability and allowing the accumulation of very large amounts of the fusion protein. The yield could be further improved by using modified *Dagt1* genes to enhance the storage lipid content in yeast ([@B19]).

One of the main advantages of the oleosin fusion technology is the simplicity of extraction and purification of the recombinant proteins accumulated in LDs from plant material. Similarly, *P. pastoris* LDs with the Ole18-PAF102 can be separated from other cellular components by simple flotation in density gradients. The yeast isolated LDs containing the Ole18-PAF102 had no activity against fungal targets, consistent with previous results with LDs from rice seeds ([@B13]). PAF102 is not active while immobilized in the LDs, requiring release from the Ole18 for activity. We speculate that this cell penetrating peptide cannot enter the fungal target cell while attached to LDs, a process that is necessary for its antifungal action ([@B39]). Once released from Ole18, PAF102 produced in *P. pastoris* was biologically active and indistinguishable from the synthetic peptide. PAF102 has potent activity against *F. proliferatum*, a plant pathogen that contaminates cereal grain with mycotoxins, reducing grain quality and causing severe economic losses ([@B57]). Here we demonstrate that biologically active PAF102 peptide can be produced quickly and efficiently in *P. pastoris* using the rice oleosin protein as a carrier to LDs.

Our results suggest that the oleosin fusion technology can be transferred to yeast cells for the production of recombinant proteins other than the AMPs here investigated. Particularly, we also successfully produced the GFP as an Ole18 fusion protein in *P. pastoris.* The main advantage of yeast over plant systems is the reduced production time. Oleosin technology in plants requires completion of the plant life cycle, since LDs are mainly accumulated in seeds: depending on the species, this could take several months whereas production in *P. pastoris* only requires several days. The production of other proteins should be evaluated to determine the robustness of the developed system.
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